about
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaEmerging concepts in pancreatic cancer medicine: targeting the tumor stromaPancreatic Cancer GeneticsMolecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic CancerFAK and paxillin, two potential targets in pancreatic cancerKey players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsRoles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic PathologiesCurrent status and progress of pancreatic cancer in ChinaFamilial Pancreatic AdenocarcinomaEpidural brain metastases in a patient with early onset pancreatic cancer: a case report and literature review.Rosa26-GFP direct repeat (RaDR-GFP) mice reveal tissue- and age-dependence of homologous recombination in mammals in vivo.Pancreatic cancer genomics: insights and opportunities for clinical translationPancreatic biomarkers: could they be the answer?Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.Pancreatic cancer, inflammation, and microbiome.Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.Molecular analysis of precursor lesions in familial pancreatic cancerExpansion of anti-mesothelin specific CD4+ and CD8+ T cell responses in patients with pancreatic carcinoma.MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.TLR9 ligation in pancreatic stellate cells promotes tumorigenesisACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromesRisk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) AnalysisPancreatic cancer: why is it so hard to treat?Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature.Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis.Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer.Familial Pancreatic Cancer and the Future of Directed Screening.Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art.LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer.Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer.ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancerMicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer.Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancerFamilial Pancreatic Cancer: To Screen or not to Screen?Pancreatic cancer risk after loss of a child: a register-based study in Sweden during 1991-2009.The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer.Development of a high risk pancreatic screening clinic using 3.0 T MRI.Evaluation of a heredofamilial cancer unit in increasing family history collection and genetic counseling referrals among Spanish oncologists at a university hospital.
P2860
Q21129230-A521BF8C-8A63-477E-BA85-C63B941A8DEAQ24627664-E23E0755-256E-4450-861C-39C13C0CA529Q26765235-B67F5F96-1B08-44BD-942C-9049DCACDA38Q26765241-C05F0403-8ED7-4B86-8FC2-B133C2579192Q26765360-4BC695BB-C2AC-4CFC-B13A-D5451F3C3525Q26766065-BD63B831-92DF-475E-B26C-9311E3FC2E9BQ26782979-72D8E35C-A0FD-43B3-A2AD-814E1B95508FQ26799739-C4285AAA-5D77-402F-A9EF-0A1F8034FEFBQ26801415-E85A88D2-81E8-4550-9064-77034A48A1EBQ30575807-90EECB5A-FAAC-4215-8EFB-E0359AC0246EQ33716551-98188297-70FC-493F-854B-C958E4AEC82FQ33781071-330599A8-CB7B-4C3D-816C-04D560526C4CQ33801371-FC25DCCD-FD53-48CB-B8A7-F83097BDE6B6Q33803923-6213ADD3-0939-4B2C-9BB5-AC27B977C630Q33956107-0326E1E8-7346-473C-B17F-EB90A843EC0FQ34093790-80B01AAC-9361-449D-98C8-50B0B3ECBB58Q34571373-BC1169F2-2632-4584-B942-B8369B5A5BF2Q35092711-718DA375-9BCC-4A93-B938-B5BB624B7F9FQ35113043-5A59763F-EEDB-4F82-BC28-D2EEC7378773Q36286020-E778AFFB-A4C2-4E14-8ADD-175719D44B98Q36416282-2149107B-C391-484D-8204-E4FB22D9DB19Q36456106-DA8DB7A9-8FE5-4134-B18E-49257470498CQ36886497-B249679A-1742-4245-AD07-B6B7BCFC75BCQ37641809-461E2B00-7AF1-491D-9B25-9C3CDA9BC184Q37684554-AB627E0A-48FD-45A7-8AB0-E9BD5BEA3BF0Q38206472-2271AD34-18EA-4694-B80B-66C4A1160887Q38441095-3C6F2D49-CDCB-4090-9C19-4F38C109E464Q38671435-7E0108A5-C83C-479E-B6DA-1B55F7BDC2D0Q38686033-76379D54-9506-4D7D-96A5-6146036AC59EQ38922182-C7611032-6300-4516-8617-F70C9DEF8ED9Q39382311-D4FFC3EC-F2F8-43DA-9AD5-4EE4F3B10F5BQ40053297-0C945AC2-A1FF-4DF9-B5D3-3C95ED01ED14Q41322585-F75B5178-1BA5-453C-90ED-7417DC9F6739Q41769515-6FCD424D-A5E7-4A3A-A527-16D24E48B5E0Q42133274-85BAA454-F716-499A-808D-F72624D1D3FBQ43102343-285D6962-7ABE-4D99-BF06-3227F6FEF5BAQ46755580-864B98FC-0DCE-4E50-B361-5E309DB50913Q50075587-463DC333-463D-4CF7-9735-3138959F9700Q50171374-297D44B2-959E-4F9A-92BE-6C68591FEC0BQ50802976-EAEAEC5A-7FD6-49E2-A805-0F2431A7CF52
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Familial pancreatic cancer--current knowledge.
@en
type
label
Familial pancreatic cancer--current knowledge.
@en
prefLabel
Familial pancreatic cancer--current knowledge.
@en
P2860
P1476
Familial pancreatic cancer--current knowledge.
@en
P2093
Detlef K Bartsch
Peter Langer
P2860
P2888
P304
P356
10.1038/NRGASTRO.2012.111
P407
P50
P577
2012-06-05T00:00:00Z